Cost-effectiveness analysis comparing conventional versus stereotactic body radiotherapy for surgically ineligible stage i non-small-cell lung cancer

Journal of Oncology Practice

Volumn 10, Issue 3, 2014, Pages e130-e136

  Mitera, Gunita ^a   Swaminath, Anand ^a   Rudoler, David ^a   Seereeram, Colleen ^a   Giuliani, Meredith ^a   Leighl, Natasha ^a   Gutierrez, Eric ^a   Dobrow, Mark J ^a   Coyte, Peter C ^a   Yung, Terence ^a   Bezjak, Andrea ^a   Hope, Andrew J ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ARTICLE; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CONVENTIONALLY FRACTIONATED RADIOTHERAPY; COST BENEFIT ANALYSIS; COST EFFECTIVENESS ANALYSIS; FEMALE; FOLLOW UP; HEALTH CARE COST; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; NON SMALL CELL LUNG CANCER; OUTCOME ASSESSMENT; OVERALL SURVIVAL; QUALITY ADJUSTED LIFE YEAR; RETROSPECTIVE STUDY; SENSITIVITY ANALYSIS; STEREOTACTIC BODY RADIATION THERAPY; CARCINOMA, NON-SMALL-CELL LUNG; COMPARATIVE STUDY; ECONOMICS; LUNG NEOPLASMS; MIDDLE AGED; MORTALITY; PATHOLOGY; RADIATION DOSE FRACTIONATION; VERY ELDERLY;

AGED; AGED, 80 AND OVER; CARCINOMA, NON-SMALL-CELL LUNG; COST-BENEFIT ANALYSIS; DOSE FRACTIONATION; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING;

EID: 84905500804     PISSN: 15547477     EISSN: 1935469X     Source Type: Journal    
DOI: 10.1200/JOP.2013.001206     Document Type: Article

References (26)

1. Institute of Medicine: Quality and patient safety. http://www.iom.edu/Global/Topics/Quality-Patient-Safety.aspx
2. Chang MY, Sugarba ker DJ: Surgery for early stage non-small cell lung cancer. Semin Surg Oncol 21:74-84, 2003
3. Sher DJ, Wee JO, Punglia RS: Cost-effectiveness analysis of stereotactic body radiotherapy and radi ofrequency ablation for medically inoperable, earlystage non-small cell lung cancer. Int J Radiat Oncol Biol Phys 81:e767-e774, 2011
4. Qiao X, Tullgren O, Lax I, et al: The role of radiotherapy in treatment of stage I non-small cell lung cancer. Lung Cancer 41:1-11, 2003
5. Timmerman R, Paulus R, Galvin J, et al: Stereotactic body radiation therapy for inoperable early stage lung cancer. JAMA 303:1070 -1076, 2010
6. Onishi H, Shirato H, Nagata Y, et al: Hypofractionated stereotactic radiotherapy (HypoFXSRT) for stage I non-small cell lung cancer: Updated results of 257 patien ts in a Japanese multi-institutional study. J Thorac Oncol 2:S94-S100, 2007 (suppl 3)
7. Weinstein MC, Skinner JA: Comparing effectiveness and health care spending: Implications for reform. N Engl J Med 362:460 -465, 2010
8. Lanni TB Jr, Grills IS, Kestin LL, et al: Stereotactic radiotherapy reduces treatment cost while improving overall survival and local control over standard fractionated radiation therapy for medically inoperable non-small-cell lung cancer . Am J Clin Oncol 34:494- 498, 2011
9. Drummond MF, Sculpher MJ, Torrance GW, et al: Methods for the Economic Evaluation of Health Care Programmes (ed 3). New York, NY, Oxford University Press, 2005
10. Dahele M,Pearson S,Purdie T,et al: Practical considerations arising from the implementation of lung stereotactic body radiation therapy (SBRT) at a comprehensive cancer center. J Thorac Oncol. 3:1332-1341, 2008.
11. Yung T, Giuliani ME, Le LW, et al: Outcomes of accelerated hypofractionated radiotherapy in stage I non-small-cell lung cancer. Curr Oncol 19:e264-e269, 2012
12. Poon I, Pintilie M, Potvin M, et al: The changing costs of radiation treatment for early prostate cancer in Ontario: A comparison between conventional and conformal external beam radiotherapy. Can J Urol 1 1:2125-2132, 2004
13. Yong JH, Beca J, McGowan T, et al: Cost-effectiveness of intensity-modulated radiotherapy in prostate cancer. Clin Oncol (R Coll Radiol) 24:521 -531, 2012
14. Yong JH, Beca J, O'Sullivan B, et al: Cost-effectiveness of intensity-modulated radiotherapy in oropharyngeal cancer. Clin Oncol (R Coll Radiol) 24:532 -538, 2012
15. Ontario Ministry of Health and Long-Term Care: Schedule of benefits for physician services under the Health Insurance Act http://www.health.gov.on.ca/english/providers/program/ohip/sob/physserv/physserv-mn.html
16. Grutters JP, Kessels AG, Pijls-Johannesma M, et al: Comparison of the effectiveness of radiotherapy with photons, protons and carbon-ions for nonsmall cell lung cancer: A meta-analysis. Radiother Oncol 95:32 -40, 2010
17. Government of Ontario: Ontario Case Costing Initiative. http://www.occp.com/mainPage.htm
18. Earle CC, Coyle D, Evans WK: Cost-effectiveness analysis in oncology. Ann Oncol 9:475-482, 1998
19. Taylor M: What is sensitivity analysis? http://www.medicine.ox.ac.uk/bandolier/painres/download/whatis/What-is-sens-analy.pdf
20. Canadian Cancer Society: Hamilton study to improve treatment for a hard-to-treat cancer receives $1.2 million in new funding: Canadian Cancer Society announces inaugural impact grants. http://www.cancer.ca/en/about-us/for-media/media-releases/ontario/2013/hamilton-study-to -improve-treatment-for-a-hard-to-treat-cancer-receives-$1,-d-,2-million-in-new-funding/?region-on
21. Pozen A, Cutler DM: Medical spending differences in the United States and Canada: The role of prices, procedures, and administrative expenses. Inquiry 47:124 -134, 2010
22. Palma D, Visser O, Lagerwaard FJ, et al: Impact of introducing stereotactic lung radiotherapy for elderly patients with stage I non-small-c ell lung cancer: A population-based time-trend analysis. J Clin Oncol 28:5153- 5159, 2010
23. Grills IS, Mangona VS, Welsh R, et al: Outcomes after stereotactic lung radiotherapy or wedge resection for stage I non-small-cell lung cancer. J Clin Oncol 28:928 -935, 2010
24. Maziak DE, Darling GE, Inculet RI, et al: Positron emission tomography in staging early lung cancer: A randomized trial. Ann Intern Med 151:221-228, W-48, 2009
25. Taremi M, Hope A, Dahele M, et al: Stereotactic body radiotherapy for medically inoperable lung cancer: Prospective, single-center study of 108 consecutive patients. Int J Radiat Oncol Biol Phys 82:967- 973, 2012
26. Haasbeek CJ, Lagerwaard FJ, Slotman BJ, et al: Outcomes of stereotactic ablative radiotherapy for centrally located early-stage lung cancer. J Thorac Oncol 6:2036 -2043, 2011